Please ensure Javascript is enabled for purposes of website accessibility

Cosmetic Dermatology


Daxxify™ is a Botox® alternative that is FDA approved to treat moderate to severe frown lines, or glabellar lines. It is the first and only peptide-formulated frown line treatment with long-lasting results of up to 9 months. Patients can expect to see results with Daxxify® as soon as the following day after treatment, and typically within two days.

Conditions treated by Daxxify™

End of content dots

News, Research and More

Stay current with California Skin Institute